KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Net Margin (2016 - 2025)

Quest Diagnostics' Net Margin history spans 17 years, with the latest figure at 7.59% for Q4 2025.

  • For Q4 2025, Net Margin rose 11.0% year-over-year to 7.59%; the TTM value through Dec 2025 reached 7.8%, up 11.0%, while the annual FY2025 figure was 8.77%, 1.0% down from the prior year.
  • Net Margin for Q4 2025 was 7.59% at Quest Diagnostics, roughly flat from 7.6% in the prior quarter.
  • Across five years, Net Margin topped out at 28.27% in Q2 2021 and bottomed at 3.26% in Q4 2022.
  • The 5-year median for Net Margin is 8.33% (2021), against an average of 9.76%.
  • The largest annual shift saw Net Margin skyrocketed 3101bps in 2021 before it crashed -1984bps in 2022.
  • A 5-year view of Net Margin shows it stood at 8.27% in 2021, then tumbled by -61bps to 3.26% in 2022, then skyrocketed by 117bps to 7.08% in 2023, then rose by 6bps to 7.48% in 2024, then increased by 2bps to 7.59% in 2025.
  • Per Business Quant, the three most recent readings for DGX's Net Margin are 7.59% (Q4 2025), 7.6% (Q3 2025), and 9.05% (Q2 2025).